These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32796711)

  • 61. Is cisplatin-induced cell death always produced by apoptosis?
    Gonzalez VM; Fuertes MA; Alonso C; Perez JM
    Mol Pharmacol; 2001 Apr; 59(4):657-63. PubMed ID: 11259608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence.
    Mirzayans R; Murray D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines.
    Chang FL; Lai MD
    Anticancer Res; 2000; 20(1A):351-5. PubMed ID: 10769679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
    Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Dai Y; Wang L; Tang J; Cao P; Luo Z; Sun J; Kiflu A; Sai B; Zhang M; Wang F; Li G; Xiang J
    Oncotarget; 2016 May; 7(18):25478-92. PubMed ID: 27009858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
    Cuddihy AR; Jalali F; Coackley C; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The anti-apoptotic role for p53 following exposure to ultraviolet light does not involve DDB2.
    Stubbert LJ; Smith JM; Hamill JD; Arcand TL; McKay BC
    Mutat Res; 2009 Apr; 663(1-2):69-76. PubMed ID: 19428372
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
    Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG
    Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
    Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultra-violet irradiation induces apoptosis via mitochondrial pathway in pancreatic cancer cells.
    Yamauchi T; Adachi S; Yasuda I; Nakashima M; Kawaguchi J; Yoshioka T; Hirose Y; Kozawa O; Moriwaki H
    Int J Oncol; 2011 Dec; 39(6):1375-80. PubMed ID: 21894434
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
    Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR
    J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines.
    Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
    Int J Cancer; 1997 Nov; 73(4):592-9. PubMed ID: 9389577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
    Beyfuss K; Hood DA
    Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
    [TBL] [Abstract][Full Text] [Related]  

  • 76. UVC-induced apoptosis in Dubca cells is independent of JNK activation and p53(Ser-15) phosphorylation.
    Chathoth S; Thayyullathil F; Hago A; Shahin A; Patel M; Galadari S
    Biochem Biophys Res Commun; 2009 Jun; 383(4):426-32. PubMed ID: 19376088
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage].
    Ceraline J; Deplanque G; Duclos B; Limacher JM; Vincent F; Goldblum S; Bergerat JP
    Bull Cancer; 1997 Nov; 84(11):1007-16. PubMed ID: 9536982
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anticancer Platinum Drugs Update.
    Ciarimboli G
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827636
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?
    Mirzayans R; Murray D
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362004
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting Strategies.
    Mirzayans R
    Curr Issues Mol Biol; 2024 May; 46(6):5379-5396. PubMed ID: 38920994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.